Literature DB >> 10411209

Hypericum perforatum extracts as potential antidepressants.

B Vitiello1.   

Abstract

Extracts of Hypericum perforatum have been used in the treatment of mild to moderate depression for many years in Europe. More recently, these extracts have become available in the USA as dietary supplements and have been popularly used to improve mood. In support of this practice, data from several controlled clinical studies suggest that Hypericum perforatum is better than placebo and as effective as established antidepressant drugs. These data have, however, several limitations that should temper our enthusiasm and argue for more research before accepting Hypericum perforatum extracts into our pharmacopoeia of established antidepressants. Extant data on the possible effects of Hypericum perforatum extracts in depression are here critically reviewed and plans for further research presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411209     DOI: 10.1211/0022357991772781

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Use of hypericum as antidepressant. Valid measure of antidepressant efficacy in primary care is needed.

Authors:  A Thornett
Journal:  BMJ       Date:  2000-04-22

2.  Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John's wort.

Authors:  Albert R Wielgus; Colin F Chignell; David S Miller; Ben Van Houten; Joel Meyer; Dan-Ning Hu; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2007 May-Jun       Impact factor: 3.421

Review 3.  Phototoxicity of traditional chinese medicine (TCM).

Authors:  Xiaoqi Li; Rui An; Kun Liang; Xinhong Wang; Lisha You
Journal:  Toxicol Res (Camb)       Date:  2018-08-27       Impact factor: 3.524

4.  Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice.

Authors:  Anil Kumar; Ruchika Garg; Atish K Prakash
Journal:  BMC Complement Altern Med       Date:  2010-05-07       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.